Skip to content

Establishment and validation of the risk prediction model of dermatomyositis combined with malignant tumor nomogram

Establishment and validation of the risk prediction model of dermatomyositis combined with malignant tumor nomogram

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031286
Enrollment
Unknown
Registered
2020-03-26
Start date
2020-03-27
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatomyositic

Interventions

Gold Standard:Clinical outcomes (whether combined with malignant tumor)
Index test:The&#32
risk&#32
prediction&#32
model&#32
of&#32
dermatomyositis&#32
combined&#32
with&#32
tumor&#32

Sponsors

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
85 Years to 1 Years

Inclusion criteria

Inclusion criteria: According to the diagnosis criteria of dermatomyositis proposed by Bohan and Peter in 1975, patients who meet any 3 or 4 criteria in 5 and 1-4 below: 1. Proximal symmetry of weak muscles in the extremities, with or without difficulty in swallowing and respiratory muscle weakness; 2. With elevated muscle enzymes; 3. With electromyography shows myogenic changes; 4. With abnormal muscle biopsy; 5. Patients with skin characteristic changes.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete clinical records and incomplete related examinations; 2. Only diagnosis as suspicious DM; 3. Patients with malignant tumors before diagnosis of dermatomyositis; 4. Patients with overlapping syndrome, that is, combined other rheumatic immune diseases (such as systemic lupus erythematosus, scleroderma, polymyositis, rheumatoid arthritis, etc.).

Design outcomes

Primary

MeasureTime frame
Consistency index;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactJunmin Zhang

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

junminmx@163.com+86 13660759167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026